Abstract
Bullous pemphigoid and pemphigus vulgaris are blistering diseases. Our results show that expression of the integrins α6β4 α3β1is altered in both diseases: α6β4 to a greater extent in the former and α3β1 in the latter disease, respectively. Instead, the extracellular matrix examined resulted normally expressed.
Keywords: bullous pemphigoid, pemphigus vulgaris, integrins
Letters in Drug Design & Discovery
Title: Expression of α6β4 and α3β1 Integrins in Bullous Pemphigoid and Pemphigus Vulgaris
Volume: 2 Issue: 3
Author(s): G. Giannelli, C. Foti, C. Divella, F. Marinosci, D. Bonamonte and S. Antonaci
Affiliation:
Keywords: bullous pemphigoid, pemphigus vulgaris, integrins
Abstract: Bullous pemphigoid and pemphigus vulgaris are blistering diseases. Our results show that expression of the integrins α6β4 α3β1is altered in both diseases: α6β4 to a greater extent in the former and α3β1 in the latter disease, respectively. Instead, the extracellular matrix examined resulted normally expressed.
Export Options
About this article
Cite this article as:
Giannelli G., Foti C., Divella C., Marinosci F., Bonamonte D. and Antonaci S., Expression of α6β4 and α3β1 Integrins in Bullous Pemphigoid and Pemphigus Vulgaris, Letters in Drug Design & Discovery 2005; 2 (3) . https://dx.doi.org/10.2174/1570180053765084
DOI https://dx.doi.org/10.2174/1570180053765084 |
Print ISSN 1570-1808 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-628X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
uPAR as Anti-Cancer Target: Evaluation of Biomarker Potential, Histological Localization, and Antibody-Based Therapy
Current Drug Targets Gold Nanoparticles - Synthesis and Applications in Cancer Management
Recent Patents on Materials Science Stathmin, Interacting with Nf-κB, Promotes Tumor Growth and Predicts Poor Prognosis of Pancreatic Cancer
Current Molecular Medicine Meet the Editorial Board:
Recent Patents on Anti-Cancer Drug Discovery Nanotechnology in Cancer Therapy: Targeting the Inhibition of Key DNA Repair Pathways
Current Molecular Medicine Novel Therapies Against Aggressive and Recurrent Epithelial Cancers by Molecular Targeting Tumor- and Metastasis-Initiating Cells and Their Progenies
Anti-Cancer Agents in Medicinal Chemistry Human Immunodeficiency Virus-Induced Apoptosis of Human Breast Cancer Cells Via CXCR4 is Mediated by the Viral Envelope Protein But Does Not Require CD4
Current HIV Research New and Highly Potent Antitumor Natural Products from Marine-Derived Fungi: Covering the Period from 2003 to 2012
Current Topics in Medicinal Chemistry Plasticity of T Cell Differentiation and Cytokine Signature: A Double-Edged Sword for Immune Responses
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Nuclear Export Mediated Regulation of MicroRNAs: Potential Target for Drug Intervention
Current Drug Targets Genetically Modified Cellular Vaccines for Therapy of Human Papilloma Virus Type 16 (HPV 16)-Associated Tumours
Current Cancer Drug Targets Weight Optimized Neural Network Using Metaheuristics for the Classification of Large Cell Carcinoma and Adenocarcinoma from Lung Imaging
Current Signal Transduction Therapy The Ovary Feels Fine when Paracrine and Autocrine Networks Cooperate with Gonadotropins in the Regulation of Folliculogenesis
Current Pharmaceutical Design Genome-Wide Integrated Analyses of Androgen Receptor Signaling in Prostate Cancer Based on High-Throughput Technology
Current Drug Targets miR-221/222 Confers Radioresistance in Glioblastoma Cells Through Activating Akt Independent of PTEN Status
Current Molecular Medicine Metallothioneins, Ageing and Cellular Senescence: A Future Therapeutic Target
Current Pharmaceutical Design Lipoprotein-Related and Apolipoprotein-Mediated Delivery Systems for Drug Targeting and Imaging
Current Medicinal Chemistry Antitumoral Potential of Snake Venom Phospholipases A2 and Synthetic Peptides
Current Pharmaceutical Biotechnology Carotenoids and Modulation of Cancer: Molecular Targets
Current Pharmacogenomics A Comprehensive Review on Nanotechnology-Based Innovations in Topical Drug Delivery for the Treatment of Skin Cancer
Current Pharmaceutical Design